Kinathera
Kinathera develops first-in-class oral drugs to treat immuno-inflammatory disorders such as Lupus-like rare or orphan diseases.
Kinathera is active in the manufacturing, pharmaceutical space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2015.
As a business in manufacturing, pharmaceutical, Kinathera is listed here with the public details available about it.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Seed.
Its team size is recorded as c_00001_00010 employees.
| Sector | Manufacturing, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2015 |
| Employees | c_00001_00010 |
| Stage | seed |
Website: kinathera.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account